An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer

Activity: Talk or presentationAcademic conference

Description

Oral presentation at the SfE British Endocrine Society conference, Edinburgh, UK, 8th-10th November 2021.
Period8 Nov 202110 Nov 2021
Held atSOCIETY FOR ENDOCRINOLOGY
Degree of RecognitionNational